Effect of patient characteristics on motor function in response to 35-50 mg of inhaled levodopa (CVT-301) in patients with Parkinson's disease: Results from a phase 2b studyP. A. LeWitt,Martin Freed,Mika Leinonen,Alexander Sedkov,Harald MurckMOVEMENT DISORDERS（2016）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
